ILMN
Illumina, Inc.
113.15
USD
This page is just a preview of the data found in TrendSpider’s full version
Illumina, Inc. stock is up 15.02% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 23 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 5 CALLs, 5 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 08 Dec 15:07 | 19 Jan, 2024 | 125.00 | 423 | ||
| 08 Dec 17:23 | 15 Mar, 2024 | 130.00 | 1011 | ||
| 08 Dec 17:48 | 21 Jun, 2024 | 125.00 | 5 | ||
| 08 Dec 17:53 | 05 Jan, 2024 | 114.00 | 1 | ||
| 08 Dec 18:38 | 15 Mar, 2024 | 105.00 | 235 | ||
| 08 Dec 18:53 | 17 Jan, 2025 | 110.00 | 33 | ||
| 08 Dec 18:53 | 21 Jun, 2024 | 115.00 | 123 | ||
| 08 Dec 20:40 | 08 Dec, 2023 | 98.00 | 39 | ||
| 08 Dec 20:52 | 19 Jan, 2024 | 230.00 | 0 | ||
| 08 Dec 20:52 | 19 Jan, 2024 | 220.00 | 53 |
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.
